Literature DB >> 15980383

In vitro antimicrobial susceptibility testing of Helicobacter felis, H. bizzozeronii, and H. salomonis.

K Van den Bulck1, A Decostere, I Gruntar, M Baele, B Krt, R Ducatelle, F Haesebrouck.   

Abstract

The susceptibilities of Helicobacter felis (15 strains), H. bizzozeronii (7 strains), and H. salomonis (3 strains) to 10 antimicrobial agents were investigated by determination of the MIC using the agar dilution method. No consistent differences were noticed between the different Helicobacter species, which were all highly susceptible to ampicillin, clarithromycin, tetracycline, tylosin, enrofloxacin, gentamicin, and neomycin, as demonstrated by low MICs. Higher MICs were obtained for lincomycin (up to 8 microg/ml) and spectinomycin (up to 4 microg/ml). Two H. felis strains showed a MIC of 16 microg/ml for metronidazole, suggesting acquired resistance to this antimicrobial agent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980383      PMCID: PMC1168705          DOI: 10.1128/AAC.49.7.2997-3000.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones.

Authors:  J E Sánchez; N G Sáenz; M R Rincón; I T Martín; E G Sánchez; M J Martínez
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

Review 2.  Helicobacter infection in dogs and cats: facts and fiction.

Authors:  R Neiger; K W Simpson
Journal:  J Vet Intern Med       Date:  2000 Mar-Apr       Impact factor: 3.333

3.  Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication.

Authors:  C Ecclissato; M A M Marchioretto; S Mendonça; A P O Godoy; R A Guersoni; M Deguer; H Piovesan; J G P Ferraz; J Pedrazzoli
Journal:  Helicobacter       Date:  2002-02       Impact factor: 5.753

4.  Effect of triple therapy on eradication of canine gastric helicobacters and gastric disease.

Authors:  I Happonen; J Linden; E Westermarck
Journal:  J Small Anim Pract       Date:  2000-01       Impact factor: 1.522

Review 5.  New Helicobacter species in humans.

Authors:  L P Andersen
Journal:  Dig Dis       Date:  2001       Impact factor: 2.404

6.  Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil.

Authors:  S Mendonça; C Ecclissato; M S Sartori; A P Godoy; R A Guerzoni; M Degger; J Pedrazzoli
Journal:  Helicobacter       Date:  2000-06       Impact factor: 5.753

Review 7.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

8.  Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.

Authors:  G Cammarota; R Cianci; O Cannizzaro; L Cuoco; G Pirozzi; A Gasbarrini; A Armuzzi; M A Zocco; L Santarelli; F Arancio; G Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

9.  Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.

Authors:  Y Glupczynski; A Burette; J F Nyst; C De Prez; E De Koster; M Deltenre
Journal:  Acta Gastroenterol Belg       Date:  1988 Jul-Oct       Impact factor: 1.316

10.  A cultured strain of "Helicobacter heilmannii," a human gastric pathogen, identified as H. bizzozeronii: evidence for zoonotic potential of Helicobacter.

Authors:  K Jalava; S L On; C S Harrington; L P Andersen; M L Hänninen; P Vandamme
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  6 in total

1.  Incidence of Helicobacter felis and the effect of coinfection with Helicobacter pylori on the gastric mucosa in the African population.

Authors:  E Lekunze Fritz; Tomas Slavik; Wayne Delport; Brenda Olivier; Schalk W van der Merwe
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 2.  Helicobacter heilmannii sensu lato: an overview of the infection in humans.

Authors:  Mario Bento-Miranda; Ceu Figueiredo
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 3.  Gastric Helicobacter species associated with dogs, cats and pigs: significance for public and animal health.

Authors:  Christophe Van Steenkiste; Freddy Haesebrouck; Emily Taillieu; Koen Chiers; Irina Amorim; Fátima Gärtner; Dominiek Maes
Journal:  Vet Res       Date:  2022-06-13       Impact factor: 3.829

4.  Bioadhesive controlled metronidazole release matrix based on chitosan and xanthan gum.

Authors:  Ala'a F Eftaiha; Nidal Qinna; Iyad S Rashid; Mayyas M Al Remawi; Munther R Al Shami; Tawfiq A Arafat; Adnan A Badwan
Journal:  Mar Drugs       Date:  2010-05-25       Impact factor: 5.118

Review 5.  Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health.

Authors:  Freddy Haesebrouck; Frank Pasmans; Bram Flahou; Koen Chiers; Margo Baele; Tom Meyns; Annemie Decostere; Richard Ducatelle
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

6.  Contingency nature of Helicobacter bizzozeronii oxygen-insensitive NAD(P)H-nitroreductase (HBZC1_00960) and its role in metronidazole resistance.

Authors:  Pradeep Kumar Kondadi; Claudia Pacini; Joana Revez; Marja-Liisa Hänninen; Mirko Rossi
Journal:  Vet Res       Date:  2013-07-16       Impact factor: 3.683

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.